Q4

TORRENT PHARMACEUTICALS LTD.

TORNTPHARMFY2622 May 2026

Revenue+27.1%

Net Profit-42.7%

OPM30.74%

P&L

Quarterly Consolidated

Revenue

+27.1%4.2K

Expenditure

+45.4%3.6K

Net Profit

-42.7%364.00

NPM 8.71%-54.9%EPS ₹11.51-38.7%

vs Q3 FY26

Informational and educational content only. Not investment advice.